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Background: Fibrofatty degeneration of myocardium in ARVC is associated with wall motion abnormalities. The
aim of this study was to examine whether Cardiovascular Magnetic Resonance (CMR) based strain analysis using
feature tracking (FT) can serve as a quantifiable measure to confirm global and regional ventricular dysfunction in
ARVC patients and support the early detection of ARVC.
Methods: We enrolled 20 patients with ARVC, 30 with borderline ARVC and 22 subjects with a positive family
history but no clinical signs of a manifest ARVC. 10 healthy volunteers (HV) served as controls. 15 ARVC patients
received genotyping for Plakophilin-2 mutation (PKP-2), of which 7 were found to be positive. Cine MR datasets of
all subjects were assessed for myocardial strain using FT (TomTec Diogenes Software). Global strain and strain rate
in radial, circumferential and longitudinal mode were assessed for the right and left ventricle. In addition strain
analysis at a segmental level was performed for the right ventricular free wall.
Results: RV global longitudinal strain rates in ARVC (−0.68 ± 0.36 sec−1) and borderline ARVC (−0.85 ± 0.36 sec−1)
were significantly reduced in comparison with HV (−1.38 ± 0.52 sec−1, p ≤ 0.05). Furthermore, in ARVC patients RV
global circumferential strain and strain rates at the basal level were significantly reduced compared with HV (strain:
−5.1 ± 2.7 vs. -9.2 ± 3.6%; strain rate: −0.31 ± 0.13 sec−1 vs. -0.61 ± 0.21 sec−1). Even for patients with ARVC or
borderline ARVC and normal RV ejection fraction (n=30) global longitudinal strain rate proved to be significantly
reduced compared with HV (−0.9 ± 0.3 vs. -1.4 ± 0.5 sec−1; p < 0.005). In ARVC patients with PKP-2 mutation
there was a clear trend towards a more pronounced impairment in RV global longitudinal strain rate. On ROC
analysis RV global longitudinal strain rate and circumferential strain rate at the basal level proved to be the best
discriminators between ARVC patients and HV (AUC: 0.9 and 0.92, respectively).
Conclusion: CMR based strain analysis using FT is an objective and useful measure for quantification of wall
motion abnormalities in ARVC. It allows differentiation between manifest or borderline ARVC and HV, even if
ejection fraction is still normal.
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Arrhythmogenic right ventricular cardiomyopathy (ARVC)
is a myocardial disorder characterized by a progressive fibro-
fatty degeneration preferentially affecting the right ventricu-
lar (RV) myocardium [1]. Typical associated manifestations
comprise potentially fatal ventricular arrhythmias, electro-
cardiographic repolarisation and depolarisation changes,
structural abnormalities as well as biventricular regional and
global dysfunction.
With the fibrofatty degeneration characteristically be-
ginning in the subepicardial myocardial layer and often
being focal in distribution, myocardial biopsy usually has
only a low yield in detecting the ARVC defining histo-
pathological changes, especially in early disease stages
[2]. Instead, the diagnosis of ARVC relies on the pres-
ence of a set of major and minor criteria that were de-
fined by an International Task Force Group in 1994 and
encompass structural, functional, electrocardiographic
and histopathological as well as genetic factors [3].
Herein, imaging plays a pivotal role for the detection
of structural and functional abnormalities. Due to its
excellent capability in differentiating fatty from myo-
cardial tissue, its high sensitivity for the detection of
scar tissue and its good reproducibility in the quantifi-
cation of right ventricular dimensions, Cardiovascular
Magnetic Resonance (CMR) is nowadays commonly
used in the diagnostic workup of patients suspected of
suffering from ARVC [4].
In 2010 the task force criteria (TFC) were revised with
the aim of improving diagnostic accuracy [5]. While the
original criteria were prone to significant inter-observer
variability due to the use of a qualitative severity grading
for ventricular dilatation and systolic dysfunction, the re-
vised criteria define specific cut-off values for end-diastolic
volume and ejection fraction. Despite the inclusion of
quantitative metrics, the modified TFC still require features
that rely on a subjective image interpretation. Accordingly,
ventricular dilatation or dysfunction needs to be accom-
panied by the visual identification of regional wall motion
abnormalities in order to qualify as minor or major disease
defining criteria. The adherence to subjective features
has been viewed as a persistent weakness of the
current TFC [6].
The complex right ventricular contraction pattern
as well as the occurrence of minor contraction abnor-
malities, even in healthy subjects, significantly ham-
per a reproducible differentiation of abnormal from
normal contraction patterns and complicate the de-
tection of wall motion abnormalities particularly in
the early disease stage [7]. Strain imaging, which quanti-
fies myocardial deformation, has been proposed as a less
observer-dependent quantitative estimate for global and
regional myocardial contraction [8,9]. Several studies have
demonstrated its superiority over conventional functionalmeasures in the detection of early forms of myocardial
dysfunction [10-15].
Until recently, strain analysis in clinical routine has
been the mainstay of echocardiography [8]. While CMR
based techniques for strain analysis like myocardial tag-
ging or tissue phase contrast imaging have been available
for some time, these techniques are technically demand-
ing and have not reached clinical routine [16,17].
With the advent of new computational image analysis
tools, it is now possible to derive strain values from con-
ventional cine CMR in a retrospective manner by using
a feature-tracking algorithm [18]. There are a number of
recent studies that suggest that this new technique may
play a role in early detection and objective quantification
of contraction abnormalities in a variety of cardiac path-
ologies [19-25].
The aim of the current study was to examine whether
CMR based strain analysis using feature-tracking (FT)
can serve as a quantifiable measure to confirm global
and regional ventricular dysfunction in ARVC patients
and support the detection of even early forms of ARVC,
when global volumetric parameters are still normal.
Methods
Study population
After obtaining approval from our local ethics commit-
tee, a retrospective study was performed. We enrolled
72 patients that had been consecutively referred to our
department for CMR due to a suspected or clinically
confirmed diagnosis of ARVC (n=50) or for screening
purposes due to a positive family history for ARVC but
with no further signs of manifest disease (n=22). Prior to
CMR imaging, written informed consent was obtained from
all subjects. The final diagnosis of ARVC was established ac-
cording to the Task Force Criteria with all subjects having
been assessed for the presence of minor and major criteria.
Accordingly, the diagnosis was made when two major, one
major plus two minor or four minor criteria from different
categories were present. A diagnosis of ARVC was made in
20 out of the 50 subjects suspected of suffering from ARVC.
The remaining 30 subjects fulfilled only a fraction of the cri-
teria and were classified as borderline ARVC.
CMR images from 10 healthy volunteers (HV) served as a
control group. With ARVC being a genetically determined
heart muscle disorder, a number of mutations in genes en-
coding for structural proteins of myocardial cells have been
identified to be associated with ARVC. In 15 out of the 20
ARVC patients results from genotyping for the presence of
a Plakophilin-2 mutation (PKP-2), a proteinaceous compo-
nent of myocardial desmosomes, were available.
CMR
All CMR scans were performed on a 1.5-Tesla system
(Achieva, Philips, Best, The Netherlands). A balanced
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hold technique and with retrospective ECG-triggering
was acquired for functional analysis and subsequent
feature tracking analysis. The imaging parameters were
set as follows: echo time (TE) and repetition time (TR)
were set to shortest resulting in an average TR of
around 4 ms and a TE of 2 ms slightly varying with
slice orientation. 25 phases per cardiac cycle were ac-
quired. The acquired in-plane resolution depended on
the field of view (set according to the patient’s phys-
ique) with a mean reconstructed pixel size of 1.7 ±
0.2 mm × 1.5 ± 0.2 mm. The slice thickness was 8 mm
for both axial and short axis planes. The sequences
were exported in DICOM-Format without special
adjustments.
In all patients, the CMR protocol included a stack of
cine images in axial orientation covering the entire right
ventricle and in short axis orientation covering the entire
left ventricle to perform volumetry of the right and left
ventricle, respectively.
In addition to quantitative volumetric analysis, cine im-
ages were assessed visually for the presence of right ven-
tricular wall motion abnormalities by two experienced
observers (ACB and DM) in consensus. Severity of wall
motion abnormalities was rated depending on the detec-
tion of hypokinetic, akinetic, dyskinetic or aneurysmal seg-
ments. For quantitative and qualitative analysis, all readers
were blinded to clinical data. Qualitative image analysis
and volumetry were performed on a standard post-
processing platform (View Forum, R5.1 V1 L2, Philips,
Best, The Netherlands).
Myocardial strain analysis using CMR feature tracking
The CMR FT analysis was performed on the acquired
b-SSFP cine images using a dedicated software (Diogenes
MRI, Tomtec, Germany). The details of the feature-
tracking algorithm have been published previously [18].
The axial view at the midportion of the corresponding
atrioventricular valve was used to derive right ventricular
(RV) and left ventricular (LV) longitudinal strain values
(Figure 1A). In addition, a segmental analysis of longi-
tudinal strain at the basal, mid-ventricular and apical
portion of the RV free ventricular wall was performed.
Circumferential and radial strain parameters of both
RV and LV were determined in short axis view at a
basal, a mid-ventricular and an apical section of the
ventricle (Figure 1B). To ensure a standardized analysis
for each subject, the basal slice in short axis view was
defined as the first slice below the atrioventricular
level showing a circumferential myocardial enclosing,
the mid-ventricular slice was localized at the level of
both papillary muscles and the apical slice at an equi-
distant location between the basal and mid-ventricular
level apical to the mid-ventricular slice.For FT analysis, endocardial contours were drawn
manually in end-diastolic images by one skilled observer
with subsequent software-driven automatic tracking of
the endocardial contour throughout the entire cardiac
cycle. The quality of automatic tracking was checked
and contours were manually adjusted and tracking re-
peated if necessary. Strain and strain rate were derived
on a segmental and on a global level on axial and short
axis images.
Statistical analysis
For statistical analysis, the PASW 18.0 software package
(IBM) was used. All continuous data are given as mean
± standard deviation. To test for significant differences
between patient and control groups as well as patient
subgroups, analysis of variance (ANOVA) testing was
performed. For post-hoc analysis of multiple paired-
group comparisons, Bonferroni correction was applied.
For all patients with a diagnosis of ARVC or borderline
ARVC, a subgroup analysis was performed for different
ranges of ejection fractions, graded according to the cut-
off values as defined in the TF criteria, and for the ab-
sence vs. the presence of wall motion abnormalities.
Patients with available data from genotyping for PKP-2
mutations were compared for differences in conven-
tional functional and strain parameters depending on
their mutation status using the Mann–Whitney-U-Test.
The diagnostic accuracy of global functional and strain
parameters was evaluated for all patients with a diagno-
sis of ARVC (n=20) using receiver operating curve
(ROC) analysis with ≥ 4 points in TF criteria (major
criteria = 2 points, minor criteria = 1 point) as the gold
standard. Optimal cut-off values were identified to
achieve a high sensitivity and a reasonable high specifi-
city (≥70%) for the detection of the disease. A p-value
of <0.05 was regarded statistically significant.
Results
Basic demographic and volumetric data
Demographic characteristics and basic diagnostic data of
the four study groups including the mean Task Force
Score (TFS), the severity of wall motion abnormalities
(WMA) and the strength of subgroups divided depend-
ing on ejection fraction subdivisions (EF) as well as RV
and LV volumetric data are presented in Table 1.
Healthy volunteers and subjects with a positive family
history of ARVC were significantly younger than patients
with a diagnosis of ARVC and borderline ARVC.
In ARVC patients, RVEDVI and RVESVI were signifi-
cantly higher and RVEF was significantly reduced com-
pared to all other groups (Figure 2). In borderline ARVC
patients, RVEF was significantly reduced compared to
healthy volunteers. In contrast, LVEDVI, LVESVI and
LVEF did not differ significantly among the 4 groups.
Figure 1 Tracked right and left ventricular endocardial contours in axial (A) and short axis orientation (B) at the apical, mid-ventricular
and basal level.
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Right ventricular global strain and strain rate parameters
are given in Table 2. RV global longitudinal strain rate was
significantly reduced in ARVC patients in comparison
with healthy volunteers (−0.68 ± 0.36% sec−1 vs. -1.38 ±
0.52 sec−1; p ≤ 0.005) and subjects with a positive family
history (−1.22 ± 0.73 sec−1; p ≤ 0.01) (Figure 3). Also, bor-
derline ARVC patients showed significantly reduced
longitudinal strain rates compared with healthy volun-
teers (−0.85 ± 0.36 sec−1 vs. -1.38 ± 0.52 sec−1, respect-
ively; p ≤ 0.05).
Furthermore, in patients with a confirmed diagnosis of
ARVC circumferential (Figure 4) and radial strain rates
were significantly impaired at the basal level in short
axis view when compared to healthy volunteers or sub-
jects with a positive family history. The same was true
for the circumferential strain values at the basal level
compared to healthy volunteers.
Segmental longitudinal strain analysis of the free right
ventricular wall revealed significantly lower strain ratesin the basal and apical segments for patients with ARVC
(basal: −1.4 ± 0.8 sec−1, p < 0.005; apical: −0.8 ± 0.1 sec−1,
p < 0.05) and in the basal segment for borderline ARVC
(basal: −1,8 ± 0.2 sec−1, p < 0.005; apical: −1.1 ± 0.1 sec−1)
compared to healthy volunteers (basal: − 5.5 ± 2.2 sec−1;
apical: −1.6 ± 0.2 sec−1). At the medial segment, no signifi-
cant differences were found.
On left ventricular strain analysis, the longitudinal
strain rate (−0.7 ± 0.2 vs. -1.2 ± 0.5 sec−1; p < 0.05) as
well as the circumferential strain rate at the basal level
(−1.1 ± 0.3 vs. -1.4 ± 0.3 sec−1; p < 0.05) were signifi-
cantly reduced in ARVC patients compared to healthy
volunteers. Additionally, patients with borderline ARVC
had reduced peak circumferential strain rates at the
basal left ventricular level compared to healthy volun-
teers (−1.1 ± 0.3 vs. -1.4 ± 0.3 sec−1; p < 0.05, Figure 5).
All other right and global left ventricular strain and
strain rate parameters were not significantly different on
post-hoc analysis between patient groups and healthy
volunteers when applying Bonferroni correction.
Figure 2 Comparison of right ventricular ejection fraction between healthy volunteers and patient groups.
Table 1 Basic demographics, volumetric data and patient characteristics
Healthy volunteers ARVC Borderline ARVC pos. family history
n 10 20 30 22
Sex (m/w) 5/5 17/3 19/11 16/6
Age 24.3 ± 3.0 50.7 ± 16.9*,# 41.4 ± 14.5*,# 29.3 ± 11.7
Weight (kg) 66.4 ± 9.4 81.3 ± 17.3 80.7 ± 16.7 80.3 ± 15.7
Height (cm) 176.1 ± 9.1 178.4 ± 8.0 175.6 ± 8.5 179.3 ± 9.0
Body surface area (m2) 1.81 ± 0.17 1.99 ± 0.22 1.96 ± 0.22 1.99 ± 0.22
RVEDVI (ml/m2) 88.1 ± 12.8 124.4 ± 40.4*,$,# 100.4 ± 31.9 93.2 ± 15.0
RVESVI (ml/m2) 36.7 ± 6.4 78.0 ± 39.8**,$,## 53.2 ± 25.0 45.7 ± 10.8
RVEF (%) 58.3 ± 4.8 40.4 ± 10.9**,$$,## 49.2 ± 8.4* 52.6 ± 6.9
LVEDVI (ml/m2) 79.0 ± 8.2 84.3 ± 18.8 89.4 ± 20.6 88.7 ± 13.2
LVESVI (ml/m2) 28.8 ± 4.5 33.5 ± 14.5 37.7 ± 13.3 35.4 ± 7.1
LVEF (%) 63.6 ± 4.2 60.7 ± 9.2 58.2 ± 7.1 61.3 ± 5.2
Task force score 0 5.5 ± 1.4 1.4 ± 0.8 1.5 ± 0.7
WMA (n) 10/0/0/0/0 7/0/1/4/8 23/0/0/4/3 20/0/0/0/2
RVEF > 45/45 > RVEF > 40/RVEF < 40 10/0/0 8/4/8 22/5/3 20/2/0
Abbreviations: RVEDVI Right Ventricular End-diastolic Volume Index, RVESVI Right Ventricular End-systolic Volume Index, RVEF Right Ventricular Ejection
Fraction, LVEDVI Left Ventricular End-diastolic Volume Index, LVESVI Left Ventricular End-systolic Volume Index, LVEF Left Ventricular Ejection Fraction
WMA Wall Motion Abnormalities.
WMA is graded in the following order: no WMA/Hypokinesia/Akinesia/Dyskinesia/ Aneurysm.
* significant difference compared to healthy volunteers.
$ significant difference compared to borderline ARVC patients.
# significant difference compared to subjects with positive family history for ARVC.
level of significance * p < 0.05; ** p < 0.01; $$ p < 0.01; ## p < 0.01.
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Table 2 Comparison of right ventricular strain and strain rate parameters between healthy volunteers, patient groups
and subjects with positive family history for ARVC
Healthy volunteers ARVC Borderline ARVC pos. family history
RV-strain longitudinal −19.3 ± 6 −12.7 ± 7.3### −13.5 ± 6.9### −20.4 ± 4.8
circumferential basal −9.2 ± 3.6 −5.1 ± 2.7* −6.5 ± 3.1 −7.3 ± 3.9
medial −8 ± 2.8 −5 ± 3.1 −6.3 ± 3.2 −7.5 ± 3.4
apical −12.5 ± 4.5 −11.5 ± 6.6 −11.4 ± 8.3 −10 ± 5.2
radial basal 16.4 ± 7.1 11.9 ± 7.6 15.3 ± 10.2 18.2 ± 9.6
medial 12.5 ± 4.2 13.2 ± 8.4 12.5 ± 9.8 13.1 ± 6.6
apical 12 ± 7.2 14.6 ± 14.6 19.4 ± 15.3 12.5 ± 10.5
RV-strainrate global longitudinal - 1.38 ± 0.52 −0.68 ± 0.36***## −0.85 ± 0.36* 1.22 ± 0.73
circumferential basal −0.61 ± 0.21 −0.31 ± 0.13***,### −0.45 ± 0.18 −0.53 ± 0.26
medial - 0.49 ± 0.23 −0.31 ± 0.14# −0.47 ± 0.23 −0.51 ± 0.17
apical −0.9 ± 0.38 −0.78 ± 0.32 −0.92 ± 0.69 −0.79 ± 0.25
radial basal 0.82 ± 0.32 0.46 ± 0.25*,# 0.73 ± 0.38 0.79 ± 0.33
medial 0.71 ± 0.25 0,64 ± 0,26 0.67 ± 0.31 0.72 ± 0.26
apical 0.8 ± 0.22 0.82 ± 0.46 1.1 ± 0.5 1.05 ± 0.43
* significant difference compared to healthy volunteers.
$ significant difference compared to borderline ARVC patients.
# significant difference compared to subjects with positive family history for ARVC.
level of significance * p < 0.05; ** p < 0.01; *** p < 0.005; ## p < 0.01; ### p < 0.005.
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In patients with ARVC or borderline ARVC, RV global
longitudinal strain rates were reduced most significantly
in patients with an ejection fraction below 40% (n=11;
−0.5 ± 0.3 sec−1; p < 0.001; Figure 6). However, even pa-
tients with a preserved ejection fraction of more than
45% (n=30) proved to have a significant reduction in RVFigure 3 Comparison of right ventricular global longitudinal strain raglobal longitudinal strain rates when compared to
healthy volunteers (−0.9 ± 0.3 vs. -1.4 ± 0.5 sec−1; p <
0.005). Similarly, even in patients with no noticeable wall
motion abnormalities (n=30), global longitudinal RV
strain rates proved to be significantly impaired when
compared to healthy volunteers (−0.9 ± 0.4 vs. -1.4 ±
0.5 sec−1; p < 0.05; Figure 7). In patients with evidenttes between healthy volunteers and patient groups.
Figure 4 Comparison of right ventricular basal circumferential strain rates between healthy volunteers and patient groups.
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strain rate was reduced to −0.6 ± 0.3 sec−1 (p < 0.0001
for the comparison with healthy volunteers). No such dif-
ferences could be confirmed for the other assessed strain
parameters.
In patients, in which genotyping for the presence of
PKP-2 mutations had been performed, a clear trend to-
wards a more severe reduction in RV global longitu-
dinal strain rate in mutation carriers (n=7) could beFigure 5 Comparison of left ventricular basal circumferential strain raobserved (−0.5 ± 0.4 vs. -0.8 ± 0.4 sec−1), although
the observed difference did not reach the level of sig-
nificance (Figure 8).
ROC analysis
On ROC analysis (Table 3, Figure 9) RV ejection fraction
was the strongest discriminator between ARVC patients
and healthy volunteers. However, also the RV global lon-
gitudinal strain rate, the segmental longitudinal straintes between healthy volunteers and patient groups.
Figure 6 Comparison of right ventricular global longitudinal strain rates between healthy volunteers vs. ARVC and borderline ARVC
patient subgroups divided based on right ventricular ejection fraction.
Figure 7 Comparison of right ventricular global longitudinal strain rates between healthy volunteers and patient subgroups divided
based on the visual detection of wall motion abnormalities.
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Figure 8 Comparison of right ventricular global longitudinal strain rates between ARVC patients subdivided based on PKP-2 mutation
carrier status.
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strain rate at the basal level proved to be very good dis-
criminators between ARVC patients and healthy volun-
teers (AUC: 0.9, 0.92 and 0.92, respectively) outperforming
RVEDVI with an AUC of 0.83. The AUC for the low-
est longitudinal segmental strain rate of the free RVTable 3 Receiver operating curve characteristics (AUC – area


















* p < 0.05.wall was 0.91. Table 4 lists the corresponding cut-off
values for the parameters with high AUCs and the
resulting sensitivity and specificity for the detection
of ARVC. Cut-off values were chosen to achieve high
sensitivity values at reasonable high (≥70%) specificity
values.under the curve, 95% CL – Confidence Levels) for
ntricular strain and strain rate parameters

















Figure 9 Receiver operating curves of selected right ventricular conventional functional and strain parameters for differentiating
healthy volunteers from ARVC patient.
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A number of echocardiographic studies have demon-
strated the feasibility and have advocated the use of
strain analysis of the right ventricle in the diagnostic
work-up of patients with a suspected diagnosis of ARVC
[26-28]. While CMR forms an integral part in the mod-
ern diagnostic work-up of ARVC for the quantification
of conventional functional parameters, CMR-based
strain analysis, though feasible, is still technically de-
manding and not routinely performed [17,29]. With the
advent of strain analysis based on conventional cine
CMR using feature-tracking, strain analysis has now be-
come far more accessible [18].
To our knowledge, this study is the first to assess the
value of CMR feature-tracking-derived strain analysisTable 4 Optimal cut-off values of selected right ventricular
conventional functional and strain parameters and
corresponding levels of sensitivity and specificity
Parameter Cut-off Sensitivity (%) Specificity (%)
RVEDVI (ml/m2) 98.5 80 80
RVEF (%) 54 95 90
Global RV longitudinal strain
rate (%/sec)
−1.28 95 70
RV longitudinal strain rate








−0.49 95 80in the diagnostic workup of patients suspected of suf-
fering from arrhythmogenic right ventricular cardio-
myopathy. We were able to demonstrate, that FT-
derived global longitudinal as well as circumferential
strain and strain rates at the basal level of the right
ventricle were significantly reduced in patients with a
confirmed diagnosis of ARVC compared to healthy
volunteers and family relatives. Even if not as pro-
nounced, the global longitudinal strain rate also proved
to be significantly reduced in borderline ARVC pa-
tients compared to healthy volunteers.
Moreover, we found the global longitudinal strain rate
to be reduced in ARVC and borderline ARVC patients,
in which the RV ejection fraction was still preserved.
This is in accordance with a number of echocardio-
graphic studies, which have acclaimed the usefulness of
strain rate imaging in the evaluation of subclinical myo-
cardial disease in various cardiac pathologies [10-15]. In
general, strain rate describes the rate of change in myo-
cardial deformation with respect to time and has been
found to reflect myocardial contractility best, while
strain parameters are pre-load and after-load dependent
and may change with ventricular dimensions [9]. Its high
sensitivity for subtle deteriorations of myocardial func-
tion makes strain rate a promising parameter in the de-
tection of early disease stages, when global functional
parameters may still be normal. In a recent study Teske
et al. demonstrated that echocardiographic strain ana-
lysis detects abnormal deformation in a considerable
number of asymptomatic ARVC gene carriers compared
to healthy controls [26].
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fact that it allows for obtaining objective, quantifiable
measures that are less operator-dependent than a mere
visual wall motion analysis. Visual wall motion analysis
is prone to significant inter-observer variability, particu-
larly in case of the right ventricle due to its complex
contraction pattern [30,31]. In our study, global longitu-
dinal strain rate was not only significantly reduced in
ARVC and borderline ARVC patients with overt wall
motion abnormalities, but also patients with no apparent
wall motion abnormalities proved to have significantly
reduced global RV longitudinal strain rate.
At a segmental level, we found a significant reduction
in strain rate values at the basal and the apical segment
of the right ventricular wall. In conjunction with the
right ventricular outflow tract these two segments form
the so-called triangle of dysplasia and represent the sites
of predilection for the manifestation of ARVC-related
functional and structural changes [1]. However, while
echocardiographic strain studies are usually performed
at a segmental level, segmental strain values derived
from CMR-based feature tracking need to be interpreted
with caution. A number of FT-derived strain studies
have shown that the reproducibility of segmental strain
measures is only low [32,33]. Also, our segmental strain
data are in conflict with previous echocardiographic
data, which found the segmental strain to be signifi-
cantly higher in the apical segment compared to the
basal segment [34]. In our study, strain and strain rates
were highest in the basal segment.
In contrast to the limited reproducibility of segmen-
tal strain measures, various FT-derived strain studies
have demonstrated good inter-study and inter-observer
reproducibility for global longitudinal and particularly
circumferential strain measures [20,32]. Accordingly,
global RV longitudinal strain obtained in our healthy
volunteers was in good agreement to measures pub-
lished in literature [32].
On intra-observer analysis global circumferential strain
measures have been reported to be equally well reprodu-
cible, whereas results for global RV longitudinal strain
measures are somewhat conflicting with coefficients of
variation ranging from 9.7% [20] to 28.7% [33]. While no
echocardiographic strain analysis had been performed in
our study, previous studies have found good agreement
between FT-derived global longitudinal strain values and
data derived from speckle tracking [19,20].
Data on the validity of FT-derived strain rate mea-
sures, however, are still somewhat scarce. In a recent
study, Orwat et al. found the measures of RV strain rate
to be less reproducible than global strain parameters, in-
sinuating that this might be due to the relatively limited
temporal resolution of cine CMR data [19]. So far, no data
exists about the extent to which strain rate measures areinfluenced by the temporal resolution of cine CMR data,
which is considerably lower than the frame rates used in
echocardiographic strain analyses.
In a subgroup of our ARVC-patients, data from geno-
typing for the presence of plakophilin-2 mutations was
available. The Plakophilin-2 gene encodes for a struc-
tural component of desmosomes, which form junctions be-
tween myocardial cells [1]. Mutations in the Plakophilin-2
have been found to account for a considerable number of
inherited ARVC cases [35]. In our study, there was a trend
towards a more pronounced reduction in global RV
longitudinal strain-rate in mutation carriers. Presence
of PKP-2 mutations in ARVC correlates with earlier
onset of symptoms and arrhythmias [36]. However, the
phenotypic expression of PKP-2 mutations is known to
vary considerably [1].
On left ventricular strain analysis, global longitudinal
strain rate and circumferential strain rate at the basal
level proved to be significantly impaired in our patients
with ARVC. This finding is in line with previous studies
that have found left ventricular involvement to be a
common feature in ARVC patients even at an early dis-
ease stage [28].
By definition, all ARVC patients in our study fulfilled
the criteria established by the task force group. As right
ventricular dilatation and impaired ejection fraction are
part of the disease defining criteria, these features were
present in the majority of our patients. For that reason
the AUC values for RVEF and RVEDVI were naturally
high on ROC analysis and RVEF turned out to be the
overall best discriminator between healthy volunteers
and patients with ARVC. However, also global RV longi-
tudinal strain rate, the lowest segmental strain rate of
the free right ventricular wall and the circumferential
strain rate at the base of the RV proved to be strong dis-
criminators with high AUC values. Of all strain parame-
ters the circumferential strain rate at the base of the RV
had the highest diagnostic accuracy with a cut-off value
at −0.49%/sec.
In echocardiographic studies, the lowest segmental
strain of the free right ventricular wall has been reported
to be the best quantitative parameter for discrimination
between healthy controls and patients with a confirmed
diagnosis of ARVC [27].
Limitations
Even though our results are very promising, they still
need to be interpreted with caution. With the above-
mentioned limited evidence for the validity of FT-derived
strain rate parameters, further studies are needed to evalu-
ate the effect of varying CMR cine temporal resolution on
strain rate. Improvements to the feature-tracking algo-
rithm are needed to improve reproducibility of right ven-
tricular and particularly segmental strain analysis [33]. As
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in our subjects, a direct comparison of both methods with
respect to their diagnostic value is still missing. Thus, no
conclusive statement can be made on the superiority of
the diagnostic accuracy of either imaging modality. While
Teske et al. reported slightly higher values of AUC for
global and segmental RV strain values, Aneq et al. re-
ported that longitudinal strain measurements using
speckle tracking may be less reliable in more advanced
disease stages [27,28].
Our results are based on a relatively small number of
ARVC patients and healthy volunteers. Among our pa-
tients, we did not control for the time of disease onset
or definite diagnosis in relation to the timing of the
CMR exam, thus disease duration may have varied be-
tween groups. In a number of our patients the indication
for CMR was not for disease detection but for monitor-
ing the progression of an already known ARVC. For that
reason, some of our patients presented with a rather ad-
vanced disease stage and the overall age of our popula-
tion was higher than in other cohorts that have been
reported on in literature [5,26,27].
The control and patients groups were not age-matched.
Instead, the control group was significantly younger com-
pared to both patient groups. This may have introduced a
bias and led to an overestimation of the ARVC-related im-
pairment of longitudinal strain parameters in patients, as
longitudinal myocardial shortening has been reported to
decrease with age, even though the decrease is only mod-
erate [37]. Conversely, circumferential function has been
reported to increase with age [38]. Thus any differences of
this parameter found in our study population may even
have been slightly underestimated.
Our results were not controlled for the treatment with
antiarrhythmic drugs. While Teske et al. found no sig-
nificant difference in echocardiographic strain parame-
ters between patients with and without drug therapy
other functional and volumetric parameters, such as
heart rate, iso-volumetric acceleration and RV inflow
tract size have been described to be influenced by antiar-
rhythmic drug therapy [27].
Conclusion
In our study, we were able to demonstrate that CMR
based strain analysis using feature tracking may serve as
a valuable tool to detect and quantify impaired myocar-
dial function in ARVC patients beyond conventional
functional parameters. FT-derived strain measures allowed
for the differentiation between manifest or borderline
ARVC on the one hand and healthy volunteers or family
relatives on the other hand. Even patients, in whom ejec-
tion fraction was preserved or no wall motion abnormal-
ities had been detected on visual analysis, were found to
have impaired strain measures. In view of these findingsFT-derived CMR strain analysis promises to become a
powerful measure to further objectify diagnosis and detect
ARVC.
In order to confirm and establish its potential role in
the detection of early disease stages and to assess poten-
tial prognostic implications of FT-derived strain parame-
ters in ARVC patients, further studies with a prospective
and longitudinal design are warranted. Also, the role of
strain imaging in differentiating ARVC from other com-
mon differential diagnoses like RVOT tachycardia or
Brugada syndrome needs to be further clarified [39].
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